🔎 Trials Near Me

Pradžia › Ūmi limfoblastinė leukemija › Texas › Houston

Ūmi limfoblastinė leukemija klinikiniai tyrimai Houston, TX

28 tyrimai dėl Ūmi limfoblastinė leukemija ieško dalyvių vietose Houston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Renkami dalyviai1 fazė
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Iki 75 metų · Visoms lytims · Atnaujinta 2026-10-02 · NCT01853631

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
  • UT MD Anderson Cancer Center, Houston
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Renkami dalyviaiStebimasis tyrimas
  • Texas Children's Hospital, Houston
Amžius nuo 0 iki 38 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06131801

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Renkami dalyviai1 fazė
  • University of Texas MD Anderson Cancer Center, Houston
Amžius nuo 12 iki 78 · Visoms lytims · Atnaujinta 2026-09-29 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Renkami dalyviai2 fazė
  • MD Anderson Cancer Center, Houston
6 Months · Visoms lytims · Atnaujinta 2026-09-28 · NCT06514794

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

Renkami dalyviaiStebimasis tyrimas
  • Texas Children's Hospital, Houston
4 Weeks – 18 Years · Visoms lytims · Atnaujinta 2026-09-24 · NCT06529575

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Renkami dalyviai1/2 fazė
  • MD Anderson Cancer Center, Houston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06308588

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Renkami dalyviai1/2 fazė
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Iki 22 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Renkami dalyviai2 fazė
  • Baylor Texas Children's Hospital, Houston
Amžius nuo 7 iki 25 · Visoms lytims · Atnaujinta 2026-08-19 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

Renkami dalyviai1/2 fazė
  • MD Anderson Cancer Center, Houston
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Renkami dalyviaiStebimasis tyrimas
  • Baylor College of Medicine Houston, Houston
1 Day – 17 Years · Visoms lytims · Atnaujinta 2026-08-14 · NCT06274788

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

Renkami dalyviai2 fazė
  • The University of Texas M. D. Anderson Cancer Center, Houston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-12 · NCT07053059

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

Renkami dalyviai2 fazė
  • M D Anderson Cancer Center, Houston
Amžius 15 ir vyresni · Visoms lytims · Atnaujinta 2026-08-10 · NCT03136146

Personalized NK Cell Therapy in CBT

Renkami dalyviai2 fazė
  • M D Anderson Cancer Center, Houston
Amžius nuo 15 iki 80 · Visoms lytims · Atnaujinta 2026-07-30 · NCT02727803

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Renkami dalyviai1/2 fazė
  • Research Site, Houston
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT07109219

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Renkami dalyviaiStebimasis tyrimas
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

Renkami dalyviai1/2 fazė
  • MD Anderson Cancer Center (Data Collection Only), Houston
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-06-22 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Renkami dalyviai1/2 fazė
  • MD Anderson, Houston
Iki 1 metų · Visoms lytims · Atnaujinta 2026-06-03 · NCT05848687

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

Renkami dalyviai2 fazė
  • M D Anderson Cancer Center, Houston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-20 · NCT03263572

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Renkami dalyviaiStebimasis tyrimas
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Renkami dalyviai1 fazė
  • MD Anderson Cancer Center, Houston
Amžius 13 ir vyresni · Visoms lytims · Atnaujinta 2026-05-05 · NCT04771572

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Renkami dalyviai3 fazė
  • Ascentage Investigative Site #1501, Houston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-30 · NCT06051409

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Renkami dalyviai1/2 fazė
  • MDACC, Houston
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04988555

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Renkami dalyviai1 fazė
  • University of Texas MD Anderson Cancer Center, Houston
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-05 · NCT04260022

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Renkami dalyviai1 fazė
  • Texas Children's Hospital/Baylor College of Medicine, Houston
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2024-12-06 · NCT05476770

Ūmi limfoblastinė leukemija tyrimai kituose miestuose

Kiti tyrimai Houston

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.